Antigua and Barbuda vs Egypt: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Egypt
100.0%
in 2024
Antigua and Barbuda rank
1st
Egypt rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Egypt
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Egypt, a difference of 0.0%.
Across all 7 years both countries report, Egypt has been ahead every year.
Antigua and Barbuda ranks 1st and Egypt ranks 1st of 144 countries.
Head to head by decade
| Decade | Antigua and Barbuda | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Egypt?
- Antigua and Barbuda, at 100.0% against 100.0% in Egypt as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Egypt?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Egypt?
- 7 years are reported by both, from 2006 to 2022.
- How do Antigua and Barbuda and Egypt rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Egypt ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.